Delivery Order SPE2DB20D2104-SPE2DB26FMAAB
Award Date 10/14/25
Potential Completion Date 10/15/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count package) valued at $5,513.58. This firm fixed-price delivery order, with an ultimate completion date of July 16, 2025, represents a non-competitive award under a larger contract vehicle. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) at a ceiling value of $1,769.79. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 23, 2025, with performance at the contractor's headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's competitive...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $116,508.27. This firm fixed-price delivery order represents a non-set-aside competitive award and is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $25,044.82 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Myrbetriq ER 50 mg tablets in a quantity of 90 units, valued at $3,307.21. This is a firm fixed price, non-set-aside delivery order with a completion date of September 12, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $42,382.77 on August 27, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). The contract is classified as a firm fixed price delivery order with an ultimate completion date of August 28, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) at a ceiling value of $1,761.65. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 4, 2025. This delivery order is issued...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Myrbetriq ER 50 mg tablets (30-count units) valued at $24,075.13. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The order is due for completion by August 14, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units) under a firm fixed-price contract valued at $8,276.16. The award was made on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically 90-count tablets of Myrbetriq ER 50 mg, with a ceiling value of $10,856.63 under a firm fixed-price contract. The award was made on May 5, 2025, with an ultimate completion date of May 6, 2025. This non-competitive, non-set-aside delivery order was issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...